Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Neelesh Soman"'
Autor:
Jeanne Tie, Dirk Jäger, Victor Moreno, Dirk Nagorsen, Gloria Juan, Kyriakos P Papadopoulos, Anthony J Olszanski, Erik Rasmussen, Nehal Lakhani, Albiruni RA Razak, James M Cleary, Michael Boyer, Emiliano Calvo Aller, William Edenfield, R Donald Harvey, Annemie Rutten, Manish A Shah, David P Ryan, Hansen Wong, Neelesh Soman, Marie-Anne Damiette Smit
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background To determine the safety and efficacy of the anti-colony-stimulating factor 1 receptor (anti-CSF1R) monoclonal antibody AMG 820 in combination with pembrolizumab in patients with select solid tumors.Patients and methods Patients had advance
Externí odkaz:
https://doaj.org/article/c86d4e961e1c408ea5c8168b4d7c83df
Publikováno v:
European Medical Journal Oncology, Vol 1, Iss 1, Pp 98-104 (2013)
Soft tissue sarcomas (STS) represent a heterogeneous group of diverse neoplasms of mesenchymal origin. Once relapsed from standard therapy, STS patients have limited treatment options especially those that present with advanced or metastatic disease.
Externí odkaz:
https://doaj.org/article/f93922810d24420c87c6edf3b2bd900c
Autor:
Marie-Anne Damiette Smit, Manish A. Shah, Jeanne Tie, David P. Ryan, R. Donald Harvey, Victor Moreno, Dirk Jäger, Emilliano Calvo Aller, Neelesh Soman, James M. Cleary, William Jeffery Edenfield, Michael Boyer, Annemie Rutten, Gloria Juan, Kyriakos P. Papadopoulos, Erik Rasmussen, Dirk Nagorsen, Hansen Wong, Anthony J. Olszanski, Albiruni Ryan Abdul Razak, Nehal Lakhani
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundTo determine the safety and efficacy of the anti-colony-stimulating factor 1 receptor (anti-CSF1R) monoclonal antibody AMG 820 in combination with pembrolizumab in patients with select solid tumors.Patients and methodsPatients had advanced,
Autor:
H. Henary, Neelesh Soman, Marwan Fakih, Ramaswamy Govindan, Gerald Steven Falchook, David S. Hong, G. Durm
Publikováno v:
Journal of Thoracic Oncology. 16:S28
Autor:
Gerald Steven Falchook, Marwan Fakih, David S. Hong, Neelesh Soman, H. Henary, Greg Andrew Durm, Ramaswamy Govindan
Publikováno v:
Journal of Clinical Oncology. 38:TPS3661-TPS3661
TPS3661 Background: Kirsten rat sarcoma viral oncogene homolog (KRAS) p.G12C mutation has been identified as a driver oncogenic mutation in several solid tumors (eg, non-small cell lung cancer [NSCLC], colorectal cancer [CRC]). Development of therapi
Autor:
Taofeek K. Owonikoko, Everett E. Vokes, Rene J. Boosman, Marichu Endraca, Fiona H Blackhall, Stéphane Champiat, Marie-Anne Damiette Smit, Melissa Lynne Johnson, Afshin Dowlati, Michael Boyer, Horst-Dieter Hummel, Ravi Salgia, Neelesh Soman, Luis Paz-Ares, Anne C. Chiang, Hibiki Udagawa, Christine L. Hann, Wei-Chu Victoria Lai, Hossein Borghaei, Ramaswamy Govindan
Publikováno v:
Journal of Clinical Oncology. 38:TPS9080-TPS9080
TPS9080 Background: SCLC is an aggressive neuroendocrine tumor with poor prognosis and few treatment options. Delta-like ligand 3 (DLL3) is an inhibitory Notch ligand that is highly expressed on the surface of most SCLC tumors but minimally expressed
Autor:
Neelesh Soman, D. Scott Wieland, Sant P. Chawla, Andrew F. Hendifar, Kamalesh Kumar Sankhala, Victoria S. Chua, Daniel J. Levitt, Doris Quon
Publikováno v:
Cancer. 121:570-579
BACKGROUND Aldoxorubicin, a prodrug of doxorubicin, covalently binds to serum albumin, allowing for the administration of much higher doses of doxorubicin in a previous clinical study. The current phase 1B/2 study evaluated the safety of aldoxorubici
Publikováno v:
The Journal of OncoPathology. 2:59-63
Autor:
Stefano Ferrari, Mariano Siguero, Robin L. Jones, Sant P. Chawla, Neelesh Soman, Jean-Yves Blay, Vicente Alfaro, Fariba Navid, Pilar Lardelli
Publikováno v:
Investigational New Drugs. 32:171-177
Ewing sarcoma is a rare connective tissue tumor characterized by the translocation of the EWS gene, mainly between chromosome 11 and 22, giving rise to gene re-arrangements between the EWS gene and various members of the ETS gene family. Multi-agent